Chairman s Statement 
On behalf of the board of directors (the Board ) of Shandong Weigao Group Medical Polymer Company Limited, I would like to present the audited consolidated results of the Group for the year ended 31st December, 2011 (the Year ). The Group s results in 2011 have continued to grow steadily, with prominent effect from the optimization adjustment to product mix, which laid a foundation for our 
During the year under review, the Group recorded turnover of approximately RMB3,180,577,000 (2010: RMB2,462,557,000) for the year ended 31st December, 2011, representing an increase of approximately 29.2% over the previous year and profit attributable to equity shareholders was approximately RMB3,462,172,000 (2010: RMB799,072,000), representing an increase of approximately 333.3% over the previous year. Net profit attributable to the owner of the Company excluding extraordinary item was RMB958,036,000 (2010: RMB760,628,000) representing an increase of approximately 26.0% over the previous year and basic earning per share was approximately RMB0.78. The growth in turnover and profit attributable to shareholders have been mainly due to our strategy of optimizing the product mix, focusing on the business development of blood purification products and increased the marketing and sales efforts on high value- 
During the Year, the Group continued the strategy of optimizing the product mix, focusing on the business development of blood purification products and increased the marketing and sales efforts on high value-added products such as intravenous catheters, non PVC infusion sets, specialized infusion set with dosage control device, achieving a continuous growth in turnover. Due to effective adjustments in product mix, the Group absorbed the impact of escalating raw materials and labour costs during the Year, and further increased the gross profit margin to 55.3% from 55.2% in the previous year. The performance of the Group in four business segments was as follows: (1) The growth momentum continued for consumables of the Group, reaching approximately RMB2,643,990,000 for the year ended 31st December, 2011, representing an increase of 27.3% when compared with the previous 
(2) The turnover of orthopaedic for the year was approximately RMB243,423,000, representing a growth of 38.9% when compared with the previous year.
The Distribution Joint Venture with Medtronic, Inc. in orthopaedic products contributed approximately a net profit of RMB47,224,000 to the Group for the year, representing an increase of 7.0% when compared with the previous year; (3) The turnover of haemodialysis consumables and equipment for the year was approximately RMB293,164,000, representing an increase of 39.8% when compared with the previous year. Loss attributable to Weigao Nikkiso (Weihai) Dialysis Equipment Co., Ltd. ( Weigao Nikkiso ), which is 51% held by the Group, amounted to approximately 
(4) The stent business of qqg TZBvT gPlQS (Shandong JW Medical Products Company Limited) ( JW Medical ), a 50% jointly owned entity of the Company, contributed approximately RMB106,443,000 to the profit of the Group for the nine months ended 30th September, 2011. The Company disposed of its 50% equity interest in JW Medical and an one-off profit contribution of approximately RMB2,568,534,000 was recognized by the Group. Biosensors International Pte Ltd. ( Biosensors ), which is 21.6% held by the Group, contributed approximately RMB4,195,000 to the profit of the Group. Excluding extraordinary items, Biosensors contributed approximately RMB36,595,000 to the profit of the Group.

BUSINESS REVIEW (continued) The Directors recommended the payment of a final dividend of RMB0.03 (2010: RMB0.075), which is subject to approval by the shareholders of the Company ( Shareholders ) at the forthcoming general meeting.
ANNUAL GENERAL MEETING AND CLOSURE OF REGISTER OF MEMBERS The register of members of the Company will be closed from Saturday, 21st April, 2012 to Monday, 21st May, 2012 (both days inclusive), for the purpose of determining shareholders entitlement to attend the forthcoming annual general meeting (the Annual General Meeting ), during which period no transfer of shares of the Company will be registered. In order to qualify for attending the Annual General Meeting, shareholders should ensure that all transfer documents, accompanied by the relevant share certificates, are lodged with the Company s branch share registrar, Tricor Standard Limited at 26F, Tesbury Centre, 28 Queen s Road East, Hong Kong for registration no later than 4:30 p.m. on Friday, 20th April, 2012.
In order to qualify for attending the annual 
Latest time to lodge in the transfer instrument accompanied by the share certificates 4:30 p.m., Friday, 20th April, 2012 Closure of register of members of the Company for attendance of the annual general meeting 
21st April, 2012 to Monday, 21st May, 
Latest time to lodge in the reply slip 4:30 p.m., Monday, 30th April, 2012 Date of annual general meeting Monday, 21st May, 2012 
PROPOSED FINAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS The Board recommended a final dividend of RMB0.03 per share (inclusive of tax). The total amount of final dividends to be distributed shall be approximately RMB134,291,000, of which dividends paid to non-resident corporate shareholders will be subject to the corporate tax applicable on the PRC sourced income pursuant to the PRC Corporate Income Tax Law and the Regulations on the Implementation of the PRC Corporate Income Tax Law that became effective on 1st January, 2008 and the applicable tax rate is 10%. The listed issuer will be responsible for withholding the relevant amount of tax from the dividend payment and the dividends to be received by the non-resident corporate shareholders will be net of withholding tax. The proposal to declare and pay the final dividend will be submitted to the forthcoming Annual General Meeting to be held on Monday, 21st May, 2012. Final dividend for non-listed shares will be distributed and paid in Renminbi whereas dividend for H shares will be declared in Renminbi and paid in Hong Kong dollars.
The register of members of the Company will be closed from Saturday, 26th May, 2012 to Thursday, 31st May, 2012 (both days inclusive) for the purpose of determining shareholders entitlement to final dividend for the year ended 31st December, 2011, during which period no transfer of shares of the Company will be registered. In order to qualify for entitlement of final dividend, shareholders should ensure that all transfer documents, accompanied by the relevant share certificates, are lodged with the Company s branch share registrar, Tricor Standard Limited at 26F, Tesbury Centre, 28 Queen s Road East, Hong Kong for registration no later than 4:30 p.m. on 25th May, 2012.

PROPOSED FINAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS (continued) In order to qualify to entitle the final dividend for the year ended 31st Saturday, December, 2011: Latest time to lodge in the transfer instrument accompanied by the share certificates 
Closure of register of members of the Company for the entitlement of final dividend for the year ended 31st December, 2011 
26th May, 2012 
31st May, 2012 Record date for entitlement of 
31st May, 2012 Despatch date of final dividend Friday, 15th June, 
The Group s various achievements as mentioned above are attributable to the continued supports of the staff, customers and business partners and shareholders. I would like to take this opportunity to express my most sincere thanks for all your contributions! Chen Xue Li 15th March, 2012 